Histone chaperones and cell state regulation
组蛋白伴侣和细胞状态调节
基本信息
- 批准号:10886880
- 负责人:
- 金额:$ 47.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATRX geneAffectAllelesBindingBiologyCellsChromatinCodeComplexCoupledDAXX geneDNA StructureDataDepositionDiabetes MellitusDiseaseDuct (organ) structureEmbryoEndogenous RetrovirusesEpigenetic ProcessEpithelial CellsEquilibriumFoundationsFrequenciesFutureGene ExpressionGenesGeneticGenetic ModelsGenetic TranscriptionGenomeGoalsHematopoieticHematopoietic stem cellsHeterochromatinHistologicHistone H3HistonesHomeostasisHumanHuman GenomeImpairmentIn VitroIndividualInvestigationIslet Cell TumorKnowledgeLeadLesionLinkMaintenanceMalignant NeoplasmsMediatingMediatorMetaplasiaModelingMolecularMolecular ChaperonesMusMutationNormal tissue morphologyOrganPancreasPancreatic InjuryPancreatitisPathogenicityPathologicPhenotypePhysiologicalProteinsRecoveryRecurrenceRegenerative responseRegulationRegulatory ElementRepressionResearchRoleSomatic MutationStressTimeTumor SuppressionVariantWorkderepressionembryo tissueepigenetic regulationepigenomeepigenomic profilingepigenomicshuman embryonic stem cellin vivoin vivo regenerationinduced pluripotent stem cellinfancyinjury and repairinnovationinsightloss of function mutationmouse modelmutantphysiologic modelpostnatalprogramsprotein protein interactionregenerativeresponseresponse to injurystem cell modeltissue injurytissue repairtranscriptometranscriptomic profilingtranscriptomicstumorigenesis
项目摘要
Modified Project Summary/Abstract Section
Homeostasis represents an essential balance between adjusting to changing conditions and maintaining overall stability, with perturbations contributing to diseases including diabetes, pancreatitis and cancers. Epigenetic mechanisms are central to homeostasis, including histone variants and the chaperone complexes that mediate their deposition. Histone 3.3 (H3.3) is a replacement variant for canonical histone H3 and is deposited in heterochromatin by a complex containing DAXX and ATRX. The importance of this epigenetic regulatory axis is emphasized by the early embryonic lethality of mice when any component is deleted, and recurrent somatic mutations in human cancers. This includes mutually exclusive loss-of-function mutations in DAXX or ATRX in 43% of pancreatic neuroendocrine tumors. The understanding of the physiologic functions of this regulatory complex and its component parts remains in its infancy. Emerging evidence indicates individual components regulate cellular differentiation states, including contributing to the establishment and maintenance of induced pluripotent stem cells in vitro and safeguarding hematopoietic stem cells against inappropriate differentiation in vivo. Recent work by the PI demonstrates that Daxx restricts cellular plasticity in the pancreas and maintains endogenous retroviral (ERV) silencing in vivo. This leads to the central hypothesis: As a regulator of H3.3 and heterochromatin, Daxx enforces a robust chromatin landscape that is important for the maintenance of transcriptional states and differentiation programs. The proposed studies in this project will combine comprehensive molecular and cellular analysis to dissect how Daxx regulates the epigenome, impacts gene expression, and contributes to physiologic cell state. This project will: Define Daxx-dependent regulation of the epigenome in vivo (Aim 1); and Elucidate Daxx-dependent cell state changes in a time course of pancreatic injury and recovery in vivo (Aim 2). Two new mouse models have recently been generated by the PI that abrogate the Daxx:Atrx and Daxx:H3.3 interactions respectively and subsequent studies will incorporate these innovative separation-of-function alleles to further dissect the DAXX/ATRX/H3.3 axis. Additionally, as mounting data suggests ERV repression is an important physiological function of Daxx and acknowledging the differences in repeat genomes between species, the proposed work will determine how DAXX loss affects transcriptional and cell state programs in the context of a human genome (Aim 3). Collectively, this project proposes an innovative research program that integrates powerful genetic models with comprehensive epigenomic and transcriptomic profiling to provide direct mechanistic insight into how the Daxx/Atrx/H3.3 complex contributes to chromatin maintenance and dynamics, and how perturbations impact downstream transcriptional and phenotypic states. Collectively, this work contributes to the project’s long-term goal of understanding the molecular mechanisms that maintain cellular identity and homeostasis, and the downstream pathological consequences when these mechanisms are lost.
修改后的项目摘要/摘要部分
体内平衡代表了适应不断变化的条件和维持整体稳定性之间的重要平衡,表观遗传机制是导致糖尿病、胰腺炎和癌症等疾病的关键,包括组蛋白变异和介导组蛋白 3.3 (H3) 沉积的伴侣复合物。 .3) 是典型组蛋白 H3 的替代变体,通过包含 DAXX 和 ATRX 的复合物沉积在异染色质中。该表观遗传调控轴的重要性是。任何成分被删除时小鼠的早期胚胎致死性以及人类癌症中反复发生的体细胞突变都强调了这一点,这包括 43% 的胰腺神经内分泌肿瘤中 DAXX 或 ATRX 中相互排斥的功能丧失突变。新出现的证据表明,这种调节复合体及其组成部分的功能仍处于起步阶段,各个组成部分可调节细胞分化状态,包括有助于体外诱导多能干细胞的建立和维持以及保护。 PI 最近的研究表明 Daxx 限制胰腺中的细胞可塑性并维持体内内源性逆转录病毒 (ERV) 沉默,这导致了中心假设:作为 H3.3 和异染色质的调节剂。 Daxx 强化了强大的染色质景观,这对于维持转录状态和分化程序非常重要。该项目中提出的研究将综合分子和细胞分析,以结合 Daxx 的作用。调节表观基因组,影响基因表达,并有助于生理细胞状态 该项目将: 定义体内表观基因组的 Daxx 依赖性调节(目标 1);以及 阐明胰腺损伤过程中 Daxx 依赖性细胞状态的变化。 PI 最近生成了两种新的小鼠模型,分别消除了 Daxx:Atrx 和 Daxx:H3.3 相互作用,后续研究将纳入这些创新。此外,越来越多的数据表明 ERV 抑制是 Daxx 的重要生理功能,并适应物种之间重复基因组的差异,因此拟议的工作将确定 DAXX 如何进行。损失影响人类基因组背景下的转录和细胞状态程序(目标 3),该项目提出了一项创新研究计划,将强大的遗传模型与全面的表观基因组和转录组分析相结合,以提供直接的信息。深入了解 Daxx/Atrx/H3.3 复合物如何促进染色质维持和动力学,以及扰动如何影响下游转录和表型状态。总的来说,这项工作有助于该项目的长期目标,即了解维持细胞的分子机制。身份和稳态,以及这些机制丧失时的下游病理后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amanda Rietta Wasylishen其他文献
Amanda Rietta Wasylishen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amanda Rietta Wasylishen', 18)}}的其他基金
The DAXX/ATRX/H3.3 axis in ERV regulation and tumor suppression
DAXX/ATRX/H3.3 轴在 ERV 调节和肿瘤抑制中的作用
- 批准号:
10556315 - 财政年份:2022
- 资助金额:
$ 47.09万 - 项目类别:
相似国自然基金
KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
- 批准号:
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
全基因组范围内揭示杂交肉兔等位基因特异性表达模式对杂种优势遗传基础的影响
- 批准号:32102530
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
等位基因不平衡表达对采后香蕉果实后熟与品质形成的影响
- 批准号:31972471
- 批准年份:2019
- 资助金额:57 万元
- 项目类别:面上项目
高温影响水稻不同Wx等位基因表达及直链淀粉含量的分子机制研究
- 批准号:31500972
- 批准年份:2015
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
- 批准号:
10590033 - 财政年份:2024
- 资助金额:
$ 47.09万 - 项目类别:
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 47.09万 - 项目类别:
Development of a SYF2 antisense oligonucleotide treatment for ALS and FTD
开发治疗 ALS 和 FTD 的 SYF2 反义寡核苷酸
- 批准号:
10547625 - 财政年份:2023
- 资助金额:
$ 47.09万 - 项目类别:
Role of apoE-mediated meningeal lymphatic remodeling in the pathophysiology of Alzheimer’s disease
apoE 介导的脑膜淋巴重塑在阿尔茨海默病病理生理学中的作用
- 批准号:
10734287 - 财政年份:2023
- 资助金额:
$ 47.09万 - 项目类别: